This report describes and explains the medical aesthetics market and covers 2019-2024, termed the historic period, and 2024-2029, 2034F termed the forecast period. The report evaluates the market across each region and for the major economies within each region.
The global medical aesthetics market reached a value of nearly $19.17 billion in 2024, having grown at a compound annual growth rate (CAGR) of 8.67% since 2019. The market is expected to grow from $19.17 billion in 2024 to $29.69 billion in 2029 at a rate of 9.14%. The market is then expected to grow at a CAGR of 8.62% from 2029 and reach $44.9 billion in 2034.
Growth in the historic period resulted from the expanding medical tourism, growing adoption of minimally invasive and non-invasive, influence of social media and celebrities and rise in number of cosmetic procedures. Factors that negatively affected growth in the historic period were stringent regulatory standards and skepticism and safety concerns.
Going forward, increased demand for personalized beauty, rising prevalence of skin disorders and cosmetic concerns, growing aging population and expansion of beauty and wellness centers will drive the growth. Factor that could hinder the growth of the medical aesthetics market in the future include shortage of skilled professionals, high cost of treatments and impact of trade war and tariff.
North America was the largest region in the medical aesthetics market, accounting for 36.64% or $7.02 billion of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the medical aesthetics market will be Asia Pacific and South America where growth will be at CAGRs of 11.60% and 10.89% respectively. These will be followed by Middle East and Africa where the markets are expected to grow at CAGRs of 10.64% and 8.97% respectively.
The global medical aesthetics markets is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 34.54% of the total market in 2023. AbbVie Inc. was the largest competitor with 9.22% share of the market, followed by Galderma Group AG with 7.02%, Johnson & Johnson with 6.97%, Merz Pharma GmbH Co & KG with 2.66%, Sisram Medical Ltd. with 1.81%, Bausch Health Companies Inc. with 1.59%, Syneron Candela Ltd. with 1.57%, Cynosure with 1.51%, Sinclair Pharma Ltd. with 1.32% and Evolus Inc. with 0.88%.
The medical aesthetics market is segmented by product into facial aesthetic products, body contouring devices, cosmetic implants, hair removal devices, skin aesthetic devices, tattoo removal devices, thread lift products, physician-dispensed cosmeceuticals and skin lighteners, physician-dispensed eyelash products and nail treatment laser devices. The facial aesthetic products market was the largest segment of the medical aesthetics market segmented by product, accounting for 30.71% or $5.89 billion of the total in 2024. Going forward, the body contouring devices segment is expected to be the fastest growing segment in the medical aesthetics market segmented by product, at a CAGR of 12.31% during 2024-2029.
The medical aesthetics market is segmented by technology into invasive, non-invasive, minimally invasive, other technologies. The non-invasive market was the largest segment of the medical aesthetics market segmented by technology, accounting for 44.62% or $8.55 billion of the total in 2024. Going forward, the non-invasive segment is expected to be the fastest growing segment in the medical aesthetics market segmented by technology, at a CAGR of 12.99% during 2024-2029.
The medical aesthetics market is segmented by distribution channel into direct tender and retail. The direct tender market was the largest segment of the medical aesthetics market segmented by distribution channel, accounting for 64.25% or $12.32 billion of the total in 2024. Going forward, the retail segment is expected to be the fastest growing segment in the medical aesthetics market segmented by distribution channel, at a CAGR of 13.75% during 2024-2029.
The medical aesthetics market is segmented by application into anti-aging and wrinkles, facial and skin rejuvenation, breast enhancement, body shaping and cellulite, tattoo removal, vascular lesions, psoriasis and vitiligo and other applications. The facial and skin rejuvenation market was the largest segment of the medical aesthetics market segmented by application, accounting for 41.91% or $8.03 billion of the total in 2024. Going forward, the facial and skin rejuvenation segment is expected to be the fastest growing segment in the medical aesthetics market segmented by application, at a CAGR of 10.25% during 2024-2029.
The medical aesthetics market is segmented by end user into clinics, hospitals and medical spas, beauty centers and home care the clinics, hospitals and medical spas market was the largest segment of the medical aesthetics market segmented by end user, accounting for 64.85% or $12.43 billion of the total in 2024. Going forward, the clinics, hospitals and medical spas segment is expected to be the fastest growing segment in the medical aesthetics market segmented by end user, at a CAGR of 9.57% during 2024-2029.
The top opportunities in the medical aesthetics market segmented by product will arise in the facial aesthetic products segment, which will gain $3.44 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by technology will arise in the non-invasive segment, which will gain $7.2 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by distribution channel will arise in the retail segment, which will gain $6.2 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by application will arise in the facial and skin rejuvenation segment, which will gain $5.05 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by end user will arise in the clinics, hospitals, and medical spas segment, which will gain $7.2 billion of global annual sales by 2029. The medical aesthetics market size will gain the most in the USA at $2.29 billion.
Market-trend-based strategies for the medical aesthetics market include focus on focusing on developing medical-grade, biosynthetic-cellulose post-treatment dressings, focus on strategic partnerships approach to develop advanced solutions, focus on investing in the development of next-generation non-surgical skin lifting treatments, focus on developing advanced LED phototherapy treatment systems, focus on developing innovative educational platforms and focus on developing comprehensive SaaS platforms.
Player-adopted strategies in the medical aesthetics market include focus on strengthening operational capabilities through new launches and focus on expanding manufacturing capabilities through strategic partnerships.
To take advantage of the opportunities, the analyst recommends the medical aesthetics market companies to focus on enhancing post-treatment recovery solutions, focus on advancing non-surgical skin lifting solutions, focus on expanding led phototherapy treatment offerings, focus on strengthening practitioner education platforms, focus on deploying integrated saas platforms for operational efficiency, focus on scaling investments in body contouring devices, focus on accelerating non-invasive treatment portfolios, expand in emerging markets, continue to focus on developed markets, focus on building strategic partnerships to strengthen capabilities, focus on developing tiered and value-based pricing strategies, focus on strengthening digital promotion to drive awareness and engagement, focus on supporting practitioner-led promotion to improve clinical trust, focus on expanding retail channel presence to maximize growth, focus on facial and skin rejuvenation to capture highest growth opportunity, focus on home care to capture long-term growth in end-use expansion.
This product will be delivered within 3-5 business days.
The global medical aesthetics market reached a value of nearly $19.17 billion in 2024, having grown at a compound annual growth rate (CAGR) of 8.67% since 2019. The market is expected to grow from $19.17 billion in 2024 to $29.69 billion in 2029 at a rate of 9.14%. The market is then expected to grow at a CAGR of 8.62% from 2029 and reach $44.9 billion in 2034.
Growth in the historic period resulted from the expanding medical tourism, growing adoption of minimally invasive and non-invasive, influence of social media and celebrities and rise in number of cosmetic procedures. Factors that negatively affected growth in the historic period were stringent regulatory standards and skepticism and safety concerns.
Going forward, increased demand for personalized beauty, rising prevalence of skin disorders and cosmetic concerns, growing aging population and expansion of beauty and wellness centers will drive the growth. Factor that could hinder the growth of the medical aesthetics market in the future include shortage of skilled professionals, high cost of treatments and impact of trade war and tariff.
North America was the largest region in the medical aesthetics market, accounting for 36.64% or $7.02 billion of the total in 2024. It was followed by Asia Pacific, Western Europe and then the other regions. Going forward, the fastest-growing regions in the medical aesthetics market will be Asia Pacific and South America where growth will be at CAGRs of 11.60% and 10.89% respectively. These will be followed by Middle East and Africa where the markets are expected to grow at CAGRs of 10.64% and 8.97% respectively.
The global medical aesthetics markets is fairly concentrated, with large players operating in the market. The top 10 competitors in the market made up 34.54% of the total market in 2023. AbbVie Inc. was the largest competitor with 9.22% share of the market, followed by Galderma Group AG with 7.02%, Johnson & Johnson with 6.97%, Merz Pharma GmbH Co & KG with 2.66%, Sisram Medical Ltd. with 1.81%, Bausch Health Companies Inc. with 1.59%, Syneron Candela Ltd. with 1.57%, Cynosure with 1.51%, Sinclair Pharma Ltd. with 1.32% and Evolus Inc. with 0.88%.
The medical aesthetics market is segmented by product into facial aesthetic products, body contouring devices, cosmetic implants, hair removal devices, skin aesthetic devices, tattoo removal devices, thread lift products, physician-dispensed cosmeceuticals and skin lighteners, physician-dispensed eyelash products and nail treatment laser devices. The facial aesthetic products market was the largest segment of the medical aesthetics market segmented by product, accounting for 30.71% or $5.89 billion of the total in 2024. Going forward, the body contouring devices segment is expected to be the fastest growing segment in the medical aesthetics market segmented by product, at a CAGR of 12.31% during 2024-2029.
The medical aesthetics market is segmented by technology into invasive, non-invasive, minimally invasive, other technologies. The non-invasive market was the largest segment of the medical aesthetics market segmented by technology, accounting for 44.62% or $8.55 billion of the total in 2024. Going forward, the non-invasive segment is expected to be the fastest growing segment in the medical aesthetics market segmented by technology, at a CAGR of 12.99% during 2024-2029.
The medical aesthetics market is segmented by distribution channel into direct tender and retail. The direct tender market was the largest segment of the medical aesthetics market segmented by distribution channel, accounting for 64.25% or $12.32 billion of the total in 2024. Going forward, the retail segment is expected to be the fastest growing segment in the medical aesthetics market segmented by distribution channel, at a CAGR of 13.75% during 2024-2029.
The medical aesthetics market is segmented by application into anti-aging and wrinkles, facial and skin rejuvenation, breast enhancement, body shaping and cellulite, tattoo removal, vascular lesions, psoriasis and vitiligo and other applications. The facial and skin rejuvenation market was the largest segment of the medical aesthetics market segmented by application, accounting for 41.91% or $8.03 billion of the total in 2024. Going forward, the facial and skin rejuvenation segment is expected to be the fastest growing segment in the medical aesthetics market segmented by application, at a CAGR of 10.25% during 2024-2029.
The medical aesthetics market is segmented by end user into clinics, hospitals and medical spas, beauty centers and home care the clinics, hospitals and medical spas market was the largest segment of the medical aesthetics market segmented by end user, accounting for 64.85% or $12.43 billion of the total in 2024. Going forward, the clinics, hospitals and medical spas segment is expected to be the fastest growing segment in the medical aesthetics market segmented by end user, at a CAGR of 9.57% during 2024-2029.
The top opportunities in the medical aesthetics market segmented by product will arise in the facial aesthetic products segment, which will gain $3.44 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by technology will arise in the non-invasive segment, which will gain $7.2 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by distribution channel will arise in the retail segment, which will gain $6.2 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by application will arise in the facial and skin rejuvenation segment, which will gain $5.05 billion of global annual sales by 2029. The top opportunities in the medical aesthetics market segmented by end user will arise in the clinics, hospitals, and medical spas segment, which will gain $7.2 billion of global annual sales by 2029. The medical aesthetics market size will gain the most in the USA at $2.29 billion.
Market-trend-based strategies for the medical aesthetics market include focus on focusing on developing medical-grade, biosynthetic-cellulose post-treatment dressings, focus on strategic partnerships approach to develop advanced solutions, focus on investing in the development of next-generation non-surgical skin lifting treatments, focus on developing advanced LED phototherapy treatment systems, focus on developing innovative educational platforms and focus on developing comprehensive SaaS platforms.
Player-adopted strategies in the medical aesthetics market include focus on strengthening operational capabilities through new launches and focus on expanding manufacturing capabilities through strategic partnerships.
To take advantage of the opportunities, the analyst recommends the medical aesthetics market companies to focus on enhancing post-treatment recovery solutions, focus on advancing non-surgical skin lifting solutions, focus on expanding led phototherapy treatment offerings, focus on strengthening practitioner education platforms, focus on deploying integrated saas platforms for operational efficiency, focus on scaling investments in body contouring devices, focus on accelerating non-invasive treatment portfolios, expand in emerging markets, continue to focus on developed markets, focus on building strategic partnerships to strengthen capabilities, focus on developing tiered and value-based pricing strategies, focus on strengthening digital promotion to drive awareness and engagement, focus on supporting practitioner-led promotion to improve clinical trust, focus on expanding retail channel presence to maximize growth, focus on facial and skin rejuvenation to capture highest growth opportunity, focus on home care to capture long-term growth in end-use expansion.
This product will be delivered within 3-5 business days.
Table of Contents
1 Executive Summary
6 Market Characteristics
7 Major Market Trends
8 Global Medical Aesthetics Growth Analysis and Strategic Analysis Framework
9 Global Medical Aesthetics Market Segmentation
10 Medical Aesthetics Market, Regional and Country Analysis
11 Asia-Pacific Market
12 Western Europe Market
13 Eastern Europe Market
14 North America Market
15 South America Market
16 Middle East Market
17 Africa Market
18 Competitive Landscape and Company Profiles
19 Other Major and Innovative Companies
22 Key Mergers and Acquisitions
23 Recent Developments in the Medical Aesthetics Market
24 Opportunities and Strategies
25 Medical Aesthetics Market, Conclusions and Recommendations
26 Appendix
Executive Summary
Medical Aesthetics Global Market Opportunities and Strategies To 2034 provides the strategists; marketers and senior management with the critical information they need to assess the global medical aesthetics market as it emerges from the COVID-19 shut down.Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market research findings.
- Benchmark performance against key competitors.
- Utilize the relationships between key data sets for superior strategizing.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.
Description
Where is the largest and fastest-growing market for medical aesthetics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The medical aesthetics market global report answers all these questions and many more.The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider medical aesthetics market; and compares it with other markets.
The report covers the following chapters
- Introduction and Market Characteristics - Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by product, by technology, by distribution channel, by application and by end user.
- Key Trends - Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
- Growth Analysis and Strategic Analysis Framework - Analysis on PESTEL, end use industries, market growth rate, global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods, forecast growth contributors and total addressable market (TAM).
- Global Market Size and Growth - Global historic (2019-2024) and forecast (2024-2029, 2034F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
- Regional and Country Analysis - Historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison by region and country.
- Market Segmentation - Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by product, by technology, by distribution channel, by application and by end user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
- Regional Market Size and Growth - Regional market size (2024), historic (2019-2024) and forecast (2024-2029, 2034F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
- Competitive Landscape - Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
- Other Major and Innovative Companies - Details on the company profiles of other major and innovative companies in the market.\
- Competitive Benchmarking - Briefs on the financials comparison between major players in the market.
- Competitive Dashboard - Briefs on competitive dashboard of major players.
- Key Mergers and Acquisitions - Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
- Market Opportunities and Strategies - Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
- Conclusions and Recommendations - This section includes recommendations for medical aesthetics market providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
- Appendix - This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report
Markets Covered:
1) By Product: Facial Aesthetic Products; Body Contouring Devices; Cosmetic Implants; Hair Removal Devices; Skin Aesthetic Devices; Tattoo Removal Devices; Thread Lift Products; Physician-Dispensed Cosmeceuticals and Skin Lighteners; Physician-Dispensed Eyelash Products; Nail Treatment Laser Devices2) By Technology: Invasive; Non-Invasive; Minimally Invasive; Other Technologies
3) By Distribution Channel: Direct Tender; Retail
4) By Application: Anti-Aging and Wrinkles; Facial and Skin Rejuvenation; Breast Enhancement; Body Shaping and Cellulite; Tattoo Removal; Vascular Lesions; Psoriasis and Vitiligo; Other Applications
5) By End User: Clinics,Hospitals and Medical Spas; Beauty Centers; Home Care
Companies Mentioned: AbbVie Inc.; Galderma Group AG; Johnson & Johnson; Merz Pharma GmbH Co & KG; Sisram Medical Ltd.
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; UK; Italy; Spain; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; medical aesthetics indicators comparison.
Data Segmentation: Country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing:Data and analysis throughout the report is sourced using end notes.
Companies Mentioned
The companies featured in this Medical Aesthetics market report include:- AbbVie Inc.
- Galderma Group AG
- Johnson & Johnson
- Merz Pharma GmbH Co & KG
- Sisram Medical Ltd.
- Bausch Health Companies Inc.
- Syneron Candela Ltd.
- Cynosure
- Sinclair Pharma Ltd.
- Evolus Inc.
- Singclean
- Raziel Therapeutics
- IMEIK Technology Development Co., Ltd.
- Revance Biotechnology Co., Ltd.
- Huadong Medicine
- Istar Medical Aesthetics
- Kangmei Pharmaceutical Co., Ltd.
- Establishment Labs
- Alma Lasers
- Jeisys Medical
- Hugel, Inc.
- Medytox, Inc.
- Daewoong Pharmaceutical Co., Ltd.
- Hugel Pharma Co., Ltd.
- Jetema Co., Ltd.
- Vivacy
- Crown Aesthetics
- Teoxane Laboratories
- Asclepion Laser Technologies GmbH
- Fotona GmbH
- IBSA Farmaceutici Italia Srl
- Innoaesthetics S.L
- INDIBA
- Regenyal Laboratories S.R.L.
- Samyang Holdings Corp
- DermRays
- Classys
- Crown Aesthetics
- Lumenis Be. Ltd.
- INCREDIBLE Devices
- Cutera Inc.
- Allergan Aesthetics
- Crescita Therapeutics Inc
- Eclipse Med Corp. LLC
- Bausch Health Companies Inc
- xcitetech
- Fotona
- GC Aesthetics
- Establishment Labs Holdings Inc.
- Candela Corporation
- Lumenis Ltd.
- Bausch Health
- yneron Medical Ltd.
- Fotona d.o.o.
- SKIN111 Medical & Aesthetic Clinic
- Candela Corporation
- Alma Lasers, Lumenis Ltd.
- Medica Group
- Bader Sultan & Bros. Co.
- Stern Laser
- Allergan Aesthetics
- Ipsen
- Lumenis
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 380 |
| Published | September 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 19.17 Billion |
| Forecasted Market Value ( USD | $ 44.9 Billion |
| Compound Annual Growth Rate | 8.9% |
| Regions Covered | Global |
| No. of Companies Mentioned | 64 |
